Events

Philadelphia Event: Will Nationwide Venue for Patent Infringement Suits Soon End?

Events / Tuesday, Feb. 28, 2017
Noon - 1:45 p.m. EST

BakerHostetler
Cira Centre, 12th Floor
2929 Arch Street
Philadelphia, PA 19104

The American Bar Association and BakerHostetler invite you to attend a continuing legal education seminar. Facilitated by Gary Levin and John Murphy, this roundtable will explore the evolution of nationwide venue in patent infringement suits.

Specific topics to be discussed include:

  • Historical review of patent venue decisions, focusing on VE Holding Corp.
  • The Federal Circuit’s recent decision in TC Heartland and potential for Supreme Court review.
  • Is there a justification for determining venue differently for patent actions than for other civil actions?
  • Should the recent concentration of patent cases in a few jurisdictions affect venue rules?
  • Proposed legislative reform to redefine venue for patent actions.

1.5 hours of CLE credit pending.

RSVP by Feb. 21.

RSVP now >>

For questions, contact Dan Greenspan at 215.564.6525.

Event Details

DATE
  • Tuesday, Feb. 28, 2017
TIME
  • Noon to 12:15 p.m. - Registration and lunch.

Lunch will be provided.

  • 12:15 to 1:45 p.m. - Roundtable discussion
VENUE

BakerHostetler
Cira Centre, 12th Floor
2929 Arch Street
Philadelphia, PA 19104

Blog

In The Blogs

Previous Next
IP Intelligence: Insight on Intellectual Property
USPTO Memo Addresses Eligibility of Method-of-Treatment Claims in View of Federal Circuit Decision
By David N. Farsiou
June 18, 2018
In a memorandum dated June 7, 2018 (Memo), the U.S. Patent and Trademark Office (USPTO) set out new guidance concerning method-of-treatment claims, which should be welcome news for patentees. The memo addressed the decision by the U.S...
Read More ->
IP Intelligence: Insight on Intellectual Property
Additional Discovery of Clinical Trial Data in Inter Partes Review
By Timothy J. Doyle, David N. Farsiou
March 30, 2018
In Apotex, Inc. et al. v. Novartis AG (IPR 2017-00854, paper 47 dated Feb. 5, 2018), petitioner Apotex sought, and was granted, discovery of a Phase III clinical trial protocol from patent owner Novartis. The patent at issue in the IPR...
Read More ->
IP Intelligence: Insight on Intellectual Property
Core Wireless: Moving Beyond Eligibility as the Exception to the Exception?
By Brendan E. Clark
February 8, 2018
January was an exciting month for patent professionals still attempting to make sense of the fallout from the Supreme Court’s 2014 Alice Corp. v. CLS Bank International decision. Hot on the heels of its Jan. 10 decision in Finjan, Inc. v...
Read More ->
IP Intelligence: Insight on Intellectual Property
Finjan v. Blue Coat Systems: Attaching Security Profile to a Downloadable Is Patent Eligible
January 16, 2018
In Finjan v. Blue Coat Systems, the Court of Appeals for the Federal Circuit rendered a decision containing interesting rulings on patentable subject matter (affirming the District Court determination that certain claims were patent...
Read More ->
IP Intelligence: Insight on Intellectual Property
Federal Circuit Finds Lanham Act Clause Banning Immoral and Scandalous Trademarks Unconstitutional
January 9, 2018
On December 15, 2017, the Court of Appeals for the Federal Circuit struck down as unconstitutional the clause within 15 U.S.C. § 1052(a) (“Section 2(a)”) banning registration of a trademark that “[c]onsists of or comprises immoral…or...
Read More ->